Sylvester Comprehensive Cancer Center

News

Sophia George, Ph.D.

Dr. Sophia George Awarded Grant from Colleen’s Dream Foundation

07.19.2016

Sophia George, Ph.D., an obstetrics/gynecology expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was recently awarded a $10,000 grant to help discover new methods of detecting and treating ovarian cancer. The award comes from the Colleen’s Dream Foundation, an organization offering seed funding to young investigators performing cutting-edge research in ovarian cancer.

Aaron H. Wolfson, M.D.

Sylvester Researchers Show Tumor Size Can Predict Vaginal Cancer Survival

07.19.2016

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that tumor size in women with stage I or II vaginal cancer can strongly influence their overall survival. The research was published in the journal Gynecologic Oncology.

Francisco Vega, M.D.

Sylvester’s Dr. Francisco Vega speaks at Karolinska Institute in Sweden

07.19.2016

As part of a research collaboration, Francisco Vega, M.D., Ph.D., a lymphoma expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was recently invited to speak at the Department of Oncology-Pathology at the renowned Karolinska Institute in Stockholm, Sweden.

Olveen Carrasquillo, M.D., and Erin Kobetz, Ph.D., M.P.H.

Innovative Community-Based Health Screening Initiative Prepared for Launch

07.19.2016

Sylvester Comprehensive Cancer Center and other units of the University of Miami Miller School of Medicine are collaborating in the launch of an innovative health initiative to screen hard-to-reach populations in Miami-Dade County for multiple conditions and help them connect with appropriate care.

Flight Attendant Medical Research Institute Awards Breast Cancer Grants to Sylvester Scientists

07.19.2016

Three researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have been awarded new grants by the Flight Attendant Medical Research Institute, Inc., to support novel, early-stage research into breast cancer. FAMRI’s mission is to sponsor scientific and medical research for the early diagnosis and cure of diseases and medical conditions caused from exposure to tobacco smoke.

Jeong Hee Cho-Vega, M.D., Ph.D.

Molecular Diagnostics Separate Malignant from Benign Melanocytic Tumors

07.06.2016

Jeong Hee Cho-Vega, M.D., Ph.D., a skin cancer expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues have shown that a relatively simple, multi-step molecular diagnostic algorithm can help determine whether rare, atypical spitzoid tumors are benign spitz nevi or malignant melanomas.

David M. Seo, M.D.

UHealth Part of Select Collaborative Using IBM’s Watson to Tackle Major Diseases

07.06.2016

UHealth - the University of Miami Health System is part of a cognitive imaging collaborative that will be using IBM’s Watson to bring cognitive imaging into daily practice to help physicians address some of the most challenging illnesses affecting the U.S. population. UHealth is the only academic-based medical center in South Florida that is part of the collaborative.

From left, Michael Mandich, Jason Jenkins, Eric Feder, Stephen D. Nimer, M.D., and Adam Carlin.

Sylvester Comprehensive Cancer Center Hosts Cancer Moonshot Summit

07.06.2016

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine hosted a Cancer Moonshot Summit on June 29 as part of Vice President Joe Biden’s nationwide effort to make more therapies available to more patients. As a special surprise, representatives from the Miami Dolphins presented a check for more than $5 million for cancer research at Sylvester.

J. Sunil Rao, Ph.D.

Dr. J. Sunil Rao Named Interim Chair of Public Health Sciences

07.06.2016

J. Sunil Rao, Ph.D., Professor and Director of the Division of Biostatistics, has been named Interim Chair of the Department of Public Health Sciences. He is a member of Sylvester Comprehensive Cancer Center, and his primary disease area of focus has been colorectal cancer — screening for early detection, unraveling the genomic determinants of progression and projected patient response to given treatments.